Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Recommendations on the use of 18F-FDG PET in oncology 3. Use of Antiemetic Agents in Acute Gastroenteritis 4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 5. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease
Your Article Summary
See Latest ArticlesAntiretroviral Therapy With Heart
American Journal of Therapeutics, 11/25/09
Randell P et al. – Antiretroviral therapy (ART) has resulted in a substantial improvement in the morbidity and mortality associated with human immunodeficiency virus (HIV) infection. Lifestyle modification, in the first instance, and pharmacological intervention to reduce traditional risk factors are important management strategies. Initiating, or switching to, ART with a lower potential for metabolic derangement should also be considered.
Related Articles
Immune control of HIV-1 infection after therapy interruption: immediate versus deferred antiretroviral therapy
BMC Infectious Diseases, 10/20/09
Relevance Score: 67%
Interleukin-2 Therapy in Patients with HIV Infection
New England Journal of Medicine, 10/15/09
Relevance Score: 67%
Epidemiology and therapy of pain and depression during HIV and AIDS
Schmerz, 10/01/09
Relevance Score: 67%
The Hemostatic Balance in HIV-Infected Patients with and without Antiretroviral Therapy: Partial Restoration with Antiretroviral Therapy
AIDS Patient Care and STDs, 11/24/09
Relevance Score: 66%
Simplification of Antiretroviral Therapy with Tenofovir-Emtricitabine or Abacavir-Lamivudine
Clinical Infectious Diseases, 10/28/09
Relevance Score: 66%
Today in Clinical Pharmacology...keeping you current
Receive free subspecialty "5-minute updates" via email
Effect of targeting normal fasting glucose levels with basal insulin glargine on glycaemic variability and risk of hypoglycaemia: a randomized, controlled study in patients with early Type 2 diabetes
Diabetic Medicine, 02/09/10
OnabotulinumtoxinA (botulinum toxin type-A) in the prevention of migraine
Expert Opinion on Biological Therapy, 02/09/10
Capsaicin jelly against migraine pain
International Journal of Clinical Practice, 02/09/10
Article Search
Sponsor
Sponsor